Dec 4, 2009 by Brian Orelli, PhDAfter Rising 500%, What Did You Expect?A nice licensing deal, but the stock was too high to begin with.
Dec 3, 2009 by Brian Orelli, PhDHealth-Care Reform Is Very TaxingOn the industries that keep us alive.
Dec 2, 2009 by Brian Orelli, PhDOne Healthy PartnershipHumana and CVS Caremark's MinuteClinic team up.
Dec 2, 2009 by Brian Orelli, PhDTired of Waiting, Teva AdvancesWhen all else fails, just follow the established pathway to approval.
Dec 1, 2009 by Brian Orelli, PhDAbbott Makes All the Right MovesYou've got to know when to hold 'em and know when to fold 'em.
Nov 30, 2009 by Brian Orelli, PhDThe Real Problem With the Public Health-Care PlanIt's the morphing part that should scare you.
Nov 30, 2009 by Brian Orelli, PhDThe FDA Moves the GoalpostsTheravance gets its touchdown called back by the regulatory refs.
Nov 30, 2009 by Brian Orelli, PhDMaking Money More EfficientlyDrug companies shape up, and it shows in their margins.
Nov 27, 2009 by Brian Orelli, PhDA Mostly Meaningless FDA ApprovalAfter an accelerated approval, the positive effects of a full approval are minimal.
Nov 25, 2009 by Brian Orelli, PhDA Schizophrenic Move by Merck?Issue $29 billion in shares, buy back $3 billion. Say what?
Nov 25, 2009 by Brian Orelli, PhDNovartis Didn't Know JAK, Until NowA drug deal Jellyvision could be proud of.
Nov 25, 2009 by Brian Orelli, PhDStill Enjoying Those Acquisitions, Pfizer?They came with a few lawsuits as well.
Nov 24, 2009 by Brian Orelli, PhDHere's a Dollar: Go Lose Some WeightCompanies attack the wallet to try to get employees healthy.
Nov 24, 2009 by Brian Orelli, PhD52-Week Highs! What's Going On?Even with its recent leap, this stock may belong in your portfolio.
